All antidepressants to have suicide warnings

All antidepressants are to carry updated warnings on risk of suicide, according to the MHRA.

The European Medicines Agency's Pharmacovigilance Working Party (PhVWP) made the decision after the results of a meta-analysis on SSRIs and other antidepressants by the US Food and Drug Administration (FDA).

Although this review showed no increased risk of suicide in adults taking antidepressants, younger patients did have higher odds of committing suicide.

Because no clear difference was seen across the different antidepressant classes, the PhVWP has decided that all companies making antidepressant products should include warnings on suicide, particularly on the increased risk for younger people and the need for close monitoring of patients.

The written guidelines need to be in place by the beginning of March.

In the UK, the only antidepressant that can be given to adolescents is fluoxetine (Prozac) following an MHRA ruling in 2003.

MHRA report

Comment below and tell us what you think 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in